Haekang Yang
Podiatrist · New York, NYNPI 1710366265
Payments from drug & device makers
Across 46 payments — averaging $99.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Nevro Corp.$79
- Advanced Oxygen Therapy Inc.$73
- Amgen$48
- Treace Medical Concepts, Inc.$42
- AbbVie$21
- plus $19 from 1 others
What the payments were for
- Travel & lodging$2,84962%
- Food & beverage$1,73938%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 36 | $4,306 |
| Nevro Corp. | 3 | $79 |
| Advanced Oxygen Therapy Inc. | 2 | $73 |
| Amgen | 2 | $48 |
| Treace Medical Concepts, Inc. | 1 | $42 |
| AbbVie | 1 | $21 |
| Polaris Technology Solutions LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$2,269
- SALVATION$498
- Actishield$219
- VALOR$175
- CITREFIX$157
- ORTHOLOC 3DI$133
- PROPHECY$128
- AUGMENT INJECTABLE$122
How this compares
$4,588 in reported general payments places this provider in the 85th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 35 | $49,506 |
| Ciclopirox | 206 | $5,147 |
| Ammonium Lactate | 159 | $3,789 |
| Clotrimazole | 66 | $1,149 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 21 | $971 |
| Nystatin | 72 | $710 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $543 |
| Mupirocin | 62 | $401 |
| Gabapentin | 27 | $311 |
| Diclofenac Sodium | 24 | $307 |
| Meloxicam | 104 | $140 |
| Methylprednisolone | 22 | $129 |
| Terbinafine Hcl | 13 | $96 |
| Colchicine | 11 | $90 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $73 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in New York
- Elvis DanneNew York$35K
- Siddhartha SharmaNew York$13K
- Neil ZwiebelNew York$12K
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Adam CirlincioneGlen Cove$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.